STELI KOSTOV: Open Payments
NPI 1083901268 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 24 payments from 15 companies in 2025. Trend: 2023 $14 · 2024 $374 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $169 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Exact Sciences Corporation | 2 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Radius Health, Inc. | 1 | $31 |
| Amgen Inc. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
Products named: Wegovy, LEQVIO, The Cologuard Plus Collection Kit, Ozempic, Tymlos, OFEV, REXULTI, Veozah.
Industry payments across AZ — which companies pay providers there.
